VER'r year, nearly 500,000 people suffer a stroke in the United States, and nearly 200,000 die as a result of their initial event. 37 Seventy percent of these events are ischemic, and approximately twothirds are caused by major vessel occlusion. 37 It is conceivable that a surgical procedure performed acutely could either remove or bypass these major vessel lesions, and thereby reduce or abolish a major neurological deficit. 2'5'8"13"17'34 '47 If any form of acute cerebral revascularization is to be considered as a viable alternative in the management of cerebral ischemia, three questions must first be answered: 1) Is any viable tissue left which may benefit from the restoration of blood flow? 2) How quickly must blood flow be reestablished to prevent or limit severe tissue damage? and 3) What are the potential surgical risks and complications which could develop after blood flow has been restored to an area of cerebral ischemia?
The concept of improving blood flow to the ischemic penumbra, "a zone of nonfunctioning but still viable tissue that may recover its function if blood flow can be restored..-2 is the basis for our study. In this paper, we are reviewing our experience with acute cerebral revascularization in a prospective noncontrolled nonrandomized Phase I and II study of 15 patients with a sudden neurological deficit secondary to major cerebral vessel occlusion. We discuss the basic pathophysiology underlying the problem, present a review of the literature, and offer an interpretation of our data.
Summary of Cases
This study included 15 patients (six men and nine women), ranging in age from 22 to 72 years, who were admitted to Henry Ford Hospital with symptoms of acute cerebral ischemia. These patients presented with three different types of events (Table 1) : 1) transient ischemic attacks (TIA's) which were increasing in frequency, severity, and duration in the day preceding their admission (crescendo TIA's, eight patients); 2) increasing neurological deficits which were progressive and nonreversible (progressing events, three patients); and 3) stable neurological deficits which were fixed and complete (four patients). A brief summary of three representative cases follows.
A standard superficial temporal to middle cerebral artery anastomosis was completed in 14 patients, and a saphenous vein graft between the subclavian artery and a branch of the middle cerebral artery was placed in the 15th patient. Anesthesia was induced and maintained with intravenous thiopental until the anastomosis was completed. After the patient was anesthetized and the appropriate scalp area was shaved, the superficial temporal artery was traced on the scalp with Doppler ultrasonography. The scalp was surgically cleansed and draped, then an incision was made directly over the posterior branch of the superficial temporal artery, and the vessel was carefully isolated, by cauterizing and transecting all side branches. The muscle flaps were reflected and a free bone flap was elevated, the dura was tacked to the craniotomy edges and opened in a cruciate manner. The largest cortical branch of the middle cerebral artery was identified and dissected under the microscope, and a minimum number of cortical branches arising from the artery were cauterized. A fishmouth stoma was then fashioned on the superficial temporal artery at the required length, and temporary clips were applied on the previously isolated branch. An elliptical arteriotomy was made on the middle cerebral artery, an end-to-side anastomosis was completed F. G. Diaz, et al. with 10-0 monofilament nylon, and the clips were then removed. In one patient, the saphenous vein graft was harvested from the leg and anastomosed proximally to the subclavian artery and distally to the anterior temporal branch of the middle cerebral artery. One patient was kept in barbiturate coma for 3 days with thiopental serum concentrations of 30 #g/ml. After surgery, all patients remained in the intensive care unit until they were neurologically stable.
The neurological symptomatology for 10 patients resolved totally, and five patients had residual neurological deficits. Of these five, all had severe dysfunction preoperatively: crescendo TIA's in one, progressing infarction in two, and complete infarction in two. In three cases, residual deficits were mild 6 weeks after surgery. Of the two remaining patients, one had a moderate hemiparesis and the other a severe residual hemiparesis and dysphasia. On angiography 1 week after surgery, the extracranial-intracranial anastomosis was revealed to be patent in 14 patients (Table 1) , and three of the five patients with residual neurological dysfunction showed a patent bypass. One patient (Case 15) did not undergo angiography; however, Doppler ultrasonic examination showed that the superficial temporal arteries were patent. A computerized tomography (CT) scan of the patient (Case 7) who underwent a saphenous vein graft from the subclavian artery revealed a parietal intracerebral hematoma which was evacuated without disturbing the graft. The patient's hemiparesis was thus resolved, but there is a residual homonymous hemianopsia.
Representative Case Reports
Crescendo Transient Ischemic Attacks Case 8. This 40-year-old hypertensive man was admitted with a 24-hour history of recurring events of nonfiuent dysphasia. His deficit had been completely relieved after the initial events but became more severe and persistent with subsequent recurrences. On cerebral angiography there was complete left internal carotid artery occlusion (Fig. 1 ) and a CT scan showed a lowdensity area in the left parietal region. Intravenous thiopental anesthesia was begun and the patient was taken to the operating room where a left superficial temporal-middle cerebral artery anastomosis was performed. Postoperative angiography 5 days after surgery showed that the bypass filled three branches of the middle cerebral artery, and CT scanning revealed a lowdensity area in the left parietal region. The patient's symptoms resolved completely, and he was discharged Completed Infarction Case 13. This 42-year-old hypertensive woman with coronary artery disease was admitted after sudden and complete dense left hemiparesis and left central facial palsy. A cerebral angiogram showed complete right internal carotid artery occlusion (Fig. 2) . Thiopental anesthesia was started immediately, and she underwent a right superficial temporal-middle cerebral artery anastomosis. Over the next 48 hours, the left hemiparesis gradually resolved and she had no residual deficit on discharge 10 days after the operation. Postoperative angiography 4 days after surgery showed filling of four main branches of the middle cerebral artery through the anastomosis. At last follow-up review 2~ years after surgery the patient was neurologically intact.
Discussion
Normal hemispheric blood flow has been reported to be 50 ml/100 gm/min, 2' 4' 5' 7"8 and the amount of oxygen removed from the blood and utilized is estimated at 3.5 ml/100 gm/min. 4'7 When cerebral blood flow is decreased to between 16 and 20 ml/100 gm/min, 3"4 electrical failure or synaptic inactivation occurs, but cellular integrity is maintained. However, when cerebral blood flow drops below 10 to 15 ml/100 gm/min, cellular membrane integrity is lost because of failure of the sodium-potassium (Na/K) p u m p . 3 '4 The pathophysiology of regional cerebral ischemia, described in experimental animals, 7 includes three distinct areas of abnormality: a central area of infarction in which the cells suffer irreversible damage; an intermediate zone of partial ischemia, possibly the zone of penumbra; 2'3 and a peripheral zone of hyperemia. The metabolic alterations of the ischemic brain can be related to their location in each of the three zones of ischemia. In the central zone with no circulation, a sevenfold increase of anaerobic glycolysis is followed by a rapid increase in tissue lactate levels and a drop in tissue pH? -4'7'28 This leads to the failure of the Na/K pump, which allows sodium to flow into the cell and potassium to escape. These changes are associated with the shift of the oxidation reduction system to a completely reduced state, the drop of high-energy substrates, and the disappearance of carrier-mediated glucose transport across the cell membrane. 2'4'7'28 In the intermediate and peripheral zones, these changes are modulated by interaction with the collateral circulation. If blood continues to flow into these areas, glucose transport increases, as does lactic acid production and local acidosis. 2'4'28 The astrocyte can compensate for some of the metabolic changes occurring in the ischemia area; however, its ability to do so is limited and inversely related to the degree of local acidosis. 28 If the tissue pH drops significantly, the astrocytes lose their ability to assimilate metabolic by-products. The combined effect of tissue acidosis, the loss of cerebral autoregulation, vasoparalysis, the drop of high-energy phosphate substances, and the failure of the cellular membranes at the blood-brain barrier will result in the extravasation of fluid from the capillary spaces, and will determine whether cerebral edema will develop. 2'4'7'21"28,39
The traditional concept of irreversibility of cerebral ischemia was based on studies in which the entire brain was subjected to complete oxygen deprivation or total circulatory arrest. 7 This concept has recently been challenged, and it is now believed that cerebral ischemia may not necessarily produce permanent neuronal damage.8'~2'13,17'21'25"3~ Initial attempts at acute cerebral revascularization in animals have had variable degrees of success s,8,12,13,3~ ( Table 2 ). The basic problem was the need to revascularize the brain rapidly because there were no adjunctive means that would help prolong the period that the brain would tolerate ischemia without damage after it developed. Among the many drugs used to extend the time that the animal brain could tolerate lack of perfusion, were corticosteroids, 12 mannitol, 28'36'44 dimethyl sulfoxide, 12 perfluorochemicals, 36 barbiturates, 5'7,sAs,19,23,2s, 26,30,31,47 and hemodilution. 14,42,44 Of these, the most successful were barbiturates, mannitol, and hemodilution. The animal brain will tolerate temporary ischemia for 4 or 5 hours if untreated, 3-5'7'8'13'17'3s'45 It will tolerate ischemia for 6 hours or less with some form of surgical treatment. 7'8"~2'25'3~ Ischemic changes developing during this time are reversible, and the potential for ultimate total recovery in these animals is high. 3'4'7-9'25'3~
The combination of pentobarbital, thiopental, or hemodilution with acute cerebral revascularization has been the most effective protocol in limiting the development of cerebral infarction; 3~ however, the use of these medications without cerebral revascularization and vice versa has not been nearly as successful 8' 12"13"18"19 in preventing or limiting the development of cerebral infarction. All of the changes described above represent the observations made by selected investigators in experimental animals, and may not reflect the changes that develop in patients during the progression of a cerebral infarction. However, we favor the use of these concepts in our patients, because they represent experimental findings that may also occur in the clinical situation.
The time taken in evaluating patients with acute cerebral ischemia may determine their ultimate recovery. If it is accepted that ischemic tolerance for the human brain is similar to that reported for the baboon, 3~ it is important for the surgeon to establish a working diagnosis and to combine medical and surgical treatment in less than 6 hours. This "ideal period of time" may be unrealistic, since most patients are not brought to the hospital until several hours after their ischemic events have occurred. In this study, it was found that patients who had crescendo TIA's or stroke in evolution were the most likely to benefit from rapid intervention, since their deficits were not completely established. Only one of the patients who had an established neurological deficit recovered completely.
The diagnostic criteria for acute revascularization must include a neurological deficit of recent onset, preferably less than 6 hours before treatment, and one that is characterized by any of the three previously described syndromes. Computerized tomography should reveal no demonstrable abnormality, 23"36"46 and the angiogram should show a vascular lesion that is compatible with the neurological picture and is inaccessible by other surgical means. 15,23,40 It would also be desirable to obtain a cerebral blood flow study demonstrating the difference in flow between the normal hemisphere and the affected one. An attractive method to demonstrate structural integrity and regional cerebral blood flow by CT scanning can be accomplished by xenon inhalation. l~ Because the time available is 6 hours or less, it is critical that the evaluation of patients considered for acute cerebral revascularization proceed expeditiously.
Among the various available forms of medical treatment, corticosteroids 12 and anticoagulant agents 43 have few remaining advocates. Intravenous glucose infusions are discouraged because they may increase local tissue acid0sis by increasing the local generation of lactic acid. 28 Pentobarbital and thiopental are the barbiturates most often recommended in the treatment of patients with acute cerebral ischemia. 8:8' t9' 23' 25' 26"3~ Barbiturates are used because they inhibit membrane transport and synaptic activity, thereby reducing the metabolic activity of the brain by approximately 40%. 2~ '18'19'25'30'33 Volatile anesthetic drugs, like halothane, which decrease cerebral perfusion pressure by increasing the intracranial pressure through vasodilatation 19.45 are contraindicated in the management of patients with cerebral ischemia. 19"a5 Suzuki, et aL, 36 recommended intravenous mannitol immediately before major cerebral vessel occlusion, claiming that mannitol can decrease cerebral ischemia by altering the viscosity of the blood. Wood, et a/., 42"44 have recently advocated controlled normovolemic hemodilution, which, by decreasing blood viscosity and expanding the total circulating blood volume, probably increases perfusion of the ischemic brain. While it is possible that a combination of volume expansion, hemodilution, and barbiturate administration could enhance cerebral circulation and lengthen the period of ischemia tolerated by the human brain, that assessment must await a controlled randomized study. Crowell 5 and Gratzl, et al., 15 reported that patients with severe neurological deficits did not benefit from the procedure, and our experience concurs with their observations: only one of our four patients with an established deficit improved postoperatively. Possible causes for the failure of acute revascularization in patients with established deficits include the inability of any surgical procedure to restore viability to infarcted tissue, the delay in prompt intervention prior to the occurrence of neuronal death, the lack of administation of medical adjuvants during the delay prior to surgical reconstruction, or the development of irreversible cerebral edema. Some believe that acute cerebral revascularization is contraindicated. 15-17.19 There is no information currently available to determine whether any cerebral tissue in man remains viable in the early stages following cerebral ischemia. However, experimental data from animal studies suggest that this is a reasonable possibility, and that acute cerebral revascularization could be a therapeutic option. All of the patients who presented with crescendo TIA's or progressing strokes either improved or returned to normal following acute cerebral repel-fusion. Based on these observations, it is postulated that most if not all of the ischemic brain in patients with crescendo TIA's or progressing strokes has not suffered infarction. It is also possible that these patients have the greatest potential for recovery following early cerebral reperfusion. Acute cerebral revascularization, even with limited flow to the ischemic area, would probably be enough to prevent the development of neuronal death. Because the superficial temporal artery can carry approximately 20 to 60 ml of blood/100 gm/min,* the application of that flow to an area of ischemic brain could maintain normal function in approximately 100 gm of brain, or offer viability to an area of brain of approximately 250 gm. 2'4-6 Astrup, eta/., 2'4 have shown in experimental animals that the difference between electrical silence with preserved cellular integrity and failure of the Na/K pump, with loss of cell membrane integrity, is only 2 to 5 ml of blood/100 gm/min. It is logical to assume, therefore, that the balance in favor of cell preservation and tissue recovery could be provided by bringing an additional channel of blood to the ischemic brain in the acute stage. Although the amount of blood delivered by such a small channel as the superficial temporal artery may not be sufficient to restore normal function to the ischemic brain, it may be enough to maintain cell integrity until the rest of the cerebral circulation reorganizes to resupply the ischemic area. 33, 34 We are more concerned for those patients with an already established infarct, with areas of tissue damage that cannot be restored to normal by reestablishing A2-Az normal ND LDA * GSW = gunshot wound; SAH = subarachnoid hemorrhage; ICA = internal carotid artery; ICSS = internal carotid siphon stenosis; MCA = middle cerebral artery; ACoA = anterior communicating artery; Ophth = ophthalmic artery; ACA = anterior cerebral artery; MI = first portion MCA; C3 = third portion carotid siphon; Am = first portion ACA; ND = not described; pentobarb = pentobarbital; STA = superficial temporal artery: embolec = embolectomy; CT = computerized tomography; LDA = low-density area. It ICSS ND ND STA-MCA delayed patent LDA hemiparesis * GSW = gunshot wound; SAH = subarachnoid hemorrhage; ICA = internal carotid artery; ICSS = internal carotid siphon stenosis; MCA = middle cerebral artery; ACoA = anterior communicating artery; Ophth = ophthalmic artery; ACA = anterior cerebral artery; MI = first portion MCA; C3 = third portion carotid siphon; AI = first portion ACA; ND = not described; pentobarb = pentobarbital; STA = superficial temporal artery; embolec = embolectomy; CT = computerized tomography; LDA = low-density area.
blood flow. It is also possible that restoration of flow to these infarcted areas could be potentially damaging, perhaps resulting in the development of a hemorrhagic infarct. However, since we know that the amount of flow provided by a superficial temporal-middle cerebral artery anastomosis is limited, the net effect that this additional flow produces in the cerebral circulation may be enough to tip the balance in favor of recovery without changing arterial pressure in the middle cerebral artery. Reestablishing cerebral blood flow in a limited manner could be beneficial for those patients who probably have a zone of penumbra, and could enhance their potential for recovery. However, there is a lack of sufticient information on patients to determine the existence of this zone of penumbra, and further studies on the early developmental phases of human cerebral infarction should be performed.
Another issue of concern is the promptness with which cerebral blood flow can be reestablished to the ischemic tissue. Patients with crescendo TIA's or progressing strokes may have a high potential for recovery since definite cerebral damage has probably not occurred. We therefore emphasize the great urgency in evaluating and managing these patients; since the gradual progression of their ischemia and the lack of structural damage facilitate their timely treatment.
Surgical intervention in patients with an established cerebral infarct may be of questionable value. Whether a neurological deficit is an established infarction cannot be truly determined until at least 24 hours have elapsed after onset, and there is still no way of knowing if the disorder is in fact a severe neurological deficit that will resolve over time. The answer to this question must depend on a controlled randomized study of these patients treated surgically or medically. However, if one accepts that the human brain is like that of the primate in its response to ischemia, then one may assume a 4-hour "grace period" without adjunctive medical treatment and perhaps an even longer period of grace with the combination of medical adjuvants and surgery to reestablish blood flow. Nevertheless, it cannot be stated definitively that the additional blood flow provided by a small peripheral cortical anastomosis in any way affects or influences the recovery of patients with a cerebral infarction.
Finally, it must be considered whether the surgical procedure itself poses any potential risks to the patient which could lead to the development of complications after the cerebral blood flow has been established to an area of ischemic brain. Fears about the potential development of a hemorrhagic infarction 7,8,13,2~ or edema 7,8J3,21"28,36 caused by acute cerebral revascularization have not been realized in this series. One patient had CT abnormalities compatible with a well established cerebral infarction; his angiogram showed patency of the superficial temporal artery anastomosis, and a hemorrhagic infarction never developed. The single patient who underwent a saphenous vein graft from the subclavian artery to a branch of the middle cerebral artery had an intracerebral hematoma. However, after the hemorrhage was surgically evacuated and the bypass preserved, the patient recovered. In principle, it would seem appealing to provide a high-flow bypass 5'7"8'2629 '34 to an area of ischemic brain, since this would rapidly reestablish blood flow ~5"27' 42 and would also prevent any stealing from normal adjacent areas. 24' 27"38 Yet this highflow bypass has a greater potential of leading to a hemorrhagic infarction than a smaller one. In this limited group of patients, those individuals who had events in the form of crescendo TIA's or strokes in evolution benefited the most from this procedure. While their response may be attributable to the restitution of blood flow in the ischemic area, it is also possible that these patients were undergoing TIA's that might have re-versed spontaneously leaving no sequelae. Until a controlled randomized study of patients with this problem is completed, this possibility cannot be excluded.
In view of experimental evidence indicating that the ischemic brain is not necessarily permanently damaged, the availability of medical adjuvants that can prolong the viability of cerebral ischemic tissue, and this surgical experience showing that the potential for exacerbation of a cerebral infarction or for the development of a hemorrhagic infarction is limited, we believe that the applicability of acute cerebral revascularization for the ischemic brain deserves further evaluation. It is mandatory, however, that this procedure should be studied carefully in a controlled randomized study. In our limited nonrandomized noncontrolled study, we have demonstrated that this procedure has limited potential risks, can be carried out safely in patients, and has the potential to help some patients.
